Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
AGM, ahead, Al, amphetamine, Anne, attention, BST, Chairman, conclusion, deficit, diagnosed, Director, Equiniti, headcount, hyperactivity, Internet, Irish, lanadelumab, longer, meaningful, Minto, Modification, Nomination, Novimmune, PK, prodrug, rationalization, Reconsideration, Registrar, remission, Remuneration, Science, TSA, TURANDOT, understood, VEYVONDI, William, withholding
Removed:
abbreviated, Additionally, adult, Allegation, Apotex, Canada, conform, declaration, defending, designation, existed, extension, finalization, forecasted, health, human, hypoparathyroidism, informing, integrate, invalidity, judicial, label, legacy, lesser, lock, margin, NOA, noninfringement, preliminary, prohibition, protein, reclassified, reclassify, reimbursement, stay, terminated, termination, therapeutic, welfare
Filing tables
Filing exhibits
Related press release
SHPG similar filings
Filing view
External links
Exhibit 32.1
The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of Shire plc for the quarter ended June 30, 2017 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
Dr. Flemming Ornskov, the Chief Executive Officer and Jeffrey Poulton, the Chief Financial Officer of Shire plc, each certifies that, to the best of his knowledge:
| 1. | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and |
| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Shire plc. |
Date: August 3, 2017
/s/ Dr. Flemming Ornskov
Dr. Flemming Ornskov
Chief Executive Officer
/s/ Jeffrey Poulton
Jeffrey Poulton
Chief Financial Officer